Invention Grant
- Patent Title: Anti-CD73 antibodies
-
Application No.: US15647212Application Date: 2017-07-11
-
Publication No.: US10793636B2Publication Date: 2020-10-06
- Inventor: Emily Piccione Griffin , Richard A. Miller , Ian McCaffery
- Applicant: CORVUS PHARMACEUTICALS, INC.
- Applicant Address: US CA Burlingame
- Assignee: CORVUS PHARMACEUTICALS, INC.
- Current Assignee: CORVUS PHARMACEUTICALS, INC.
- Current Assignee Address: US CA Burlingame
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/28 ; A61P35/00
Abstract:
Provided herein are, inter alia, anti-CD73 antibodies and methods of using the same. The antibodies provided include amino acid substitution embodiments affecting the antibody glycosylation state. The antibodies provided herein are, inter alia, useful for the treatment of cancer and effective for inhibition of CD73 activity.
Public/Granted literature
- US20180009899A1 ANTI-CD73 ANTIBODIES Public/Granted day:2018-01-11
Information query
